Yael Mossé, MD, Featured by the Conquer Cancer Foundation
Dec 7, 2020
The CHOP physician-researcher’s investigation into cause of and treatment for neuroblastoma has been supported by Conquer Cancer grants.
Refractory Neuroblastoma Program News
Every person on your child’s team has the same goal: to give your child the best possible care. We provide medical care, emotional support and much more. Each team member has extensive experience in the treatment of refractory neuroblastoma.
New patients, referrals and second opinions
Existing patients or family members
Dr. John Maris Receives QED Award to Develop Novel Treatment for Neuroblastoma
Feb 7, 2019
A CHOP research leader received an award from the University City Science Center to help develop a new T-cell based treatment for a childhood cancer.
Children’s Hospital of Philadelphia Announces Endowed Chair in Pediatric Neuroblastoma Research
Sep 4, 2019
CHOP recipient, physician-scientist Dr. Yael Mossé, is innovating targeted, less toxic therapies for cancer affecting mostly infants and young children.
Remembering Dr. Giulio John D'Angio
Oct 30, 2018
Watch a memorial tribute to Dr. Giulio John D'Angio, pioneer in the treatment of children's cancers.
Working to Improve Cure Rates for High-risk Neuroblastoma
Nov 16, 2018
Researchers at CHOP are working to discover the fundamental mechanisms that subvert normal neural development and orchestrate neuroblastoma tumorigenesis, and then to translate this knowledge into more effective and less toxic therapies.
New Drug May Overcome Treatment Resistance in a High-risk Children’s Cancer
Jan 7, 2016
CHOP researchers have identified a powerful new drug with “unparalleled” strength against refractory types of neuroblastoma.
Grant to CHOP Funds Personalized Treatments for Children with Neuroblastoma
Dec 10, 2015
A $1.5 million grant to CHOP from Alex’s Lemonade Stand Foundation supports an innovative treatment for children with high-risk neuroblastoma.
CHOP Is a Founding Member of New NIH-Funded Research Consortium to Test New Cancer Treatments for Children
Sep 10, 2015
Building on its decades-long investigations in the biology and treatment of neuroblastoma, CHOP will lead the consortium’s neuroblastoma research program.